Immunization, Vaccines and Biologicals

Meeting of the product development group for the measles aerosol vaccine project

23-24 August 2012, London, UK

The 11th meeting of the product development group for the measles aerosol vaccine project was held in London, UK with the following specific objectives:

  • to review the merits of the trial in terms of design, methods, compliance with good clinical practices (GCP);
  • to offer an interpretation of the results (efficacy and safety);
  • to review the additional data on acceptability, cost and cost effectiveness, and
  • to recommend additional analysis, if appropriate.

The meeting sought to have the following expected outcomes:

  • to issue an overall recommendation to WHO regarding the findings of this project in the context of the Global Measles and Rubella control efforts; and
  • to outline additional research questions as appropriate.
Share